Brief: Neurosense Announces Receipt Of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement

Neurosense Therapeutics

27/12/2023 22:13

Dec 27 (Reuters) - Neurosense Therapeutics Ltd  NRSN.O :
    * NEUROSENSE ANNOUNCES RECEIPT OF NASDAQ NOTICE REGARDING
MINIMUM
STOCKHOLDERS' EQUITY REQUIREMENT
    * NEUROSENSE THERAPEUTICS - RECEIVED NOTIFICATION FROM
NASDAQ
ADVISING CO IT NO LONGER SATISFIED MINIMUM $2.5 MILLION
STOCKHOLDERS' EQUITY REQUIREMENT

Source text for Eikon:  ID:nPnb14dcKa 
Further company coverage:  NRSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))